Pharmaceutical-research company Charles River Laboratories International Inc. is expected to announce the acquisition of one of China's largest drug-research contractors, WuXi AppTec Co., for $1.6 billion, a person familiar with the matter said Sunday.
The deal reflects growing consolidation in the U.S. pharmaceutical industry as research contractors try to offer a broader range of services to drug companies.
SourceBloomberg's take
No comments:
Post a Comment